Also found in: Medical, Encyclopedia.
PMAAPetroleum Marketers Association of America
PMAAParallel Matrix Algorithms and Applications (conference)
PMAAPre-Market Approval Application (US FDA)
PMAAProduction Management Alternate Architecture
PMAAPropulsion Module Attach Assembly
PMAAPoint Mugu Alumni Association (Port Hueneme, CA)
PMAAPromotions Marketing Awards Asia
PMAAPerfectly-Matched Anisotropic Absorber
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
PVDF/PMAA blend membrane was immersed in 250.0 mL of sodium hydroxide aqueous solution (0.01 mol/L) for 24 h to transform the carboxylic acid (--COOH) of PMAA into carboxylate (--COONa), and then washed by water to remove the excess sodium hydroxide.
Binding energies of PAA, PMAA, and PEI on calcite (104) and (110) surfaces were summarized in Table 1.
The Brazilian Ambassador appreciated the efforts of PMAA for the development of Martial Arts and expressed the hope that the festival will be a milestone for the progress of Capoeira in Pakistan.
XUD SRF granule was put into the granulator rotating at 35 rpm and 3.5% w/v of PMAA solvent was poured to the XUD SRF granules under rotation.
The proposed PMAA can be divided into the vertical and horizontal antenna elements.
It has been understood that grafting by polymerization of hydrophilic PMAA improves cell compatibility [14].
However, there was ambiguous language in the PMAA which seemed designed
In 2005, the capital investment coordinating board (BKPM) issued license to four new factories--PT Asia Raya (PMDN), PT Fugui Flour & Grain Indonesia (PMA), PT Kwala Intan New Grain (PMAA) and PT Purnomo Sejati (PMDN).
"Seventeen Years of Brand Loyalty Trends: What Do They Tell Us?" PMAA Conference, March 3, 1992.
The National Biodiesel Board (NBB) together with the Petroleum Marketers Association of America (PMAA) recently introduced the Biodiesel Education Network (BEN), a new online information resource for petroleum distributors.
The Pharmaceutical Market Access Act of 2003 (PMAA) submitted to Congress on July 15, 2003 described the economics of the American pharmaceutical market as "perverse" and would allow for the importation or reimportation of non-narcotic pharmaceuticals into the United States.